On October 30, 2019 DURECT Corporation (Nasdaq: DRRX) reported that it will report third quarter and nine months ended September 30, 2019 financial results and host a conference call after the market close on Monday, November 4, 2019 (Press release, DURECT, OCT 30, 2019, https://investors.durect.com/news-releases/news-release-details/durect-corporation-announce-third-quarter-2019-financial-results?field_nir_news_date_value[min]=2019 [SID1234550054]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Monday November 4 @ 4:30pmET/1:30 p.m. Pacific Time
Toll Free:
877-407-0784
International:
201-689-8560
Conference ID:
13695661
Webcast: